Cyxone AB (publ) CYXO.ST Stock
0.1 SEK
{{ price }}
8.447487%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
20.51M SEK
LOW - HIGH [24H]
0.08
-
0.1 SEK
VOLUME [24H]
546.35K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.18 SEK
Cyxone AB (publ) Price Chart
Cyxone AB (publ) CYXO.ST Financial and Trading Overview
| Cyxone AB (publ) stock price | 0.1 SEK |
| Previous Close | 0.63 SEK |
| Open | 0.63 SEK |
| Bid | 0.6 SEK x 0 |
| Ask | 0.62 SEK x 0 |
| Day's Range | 0.58 - 0.63 SEK |
| 52 Week Range | 0.47 - 1.12 SEK |
| Volume | 74.24K SEK |
| Avg. Volume | 154.37K SEK |
| Market Cap | 61.43M SEK |
| Beta (5Y Monthly) | 0.573563 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.18 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CYXO.ST Valuation Measures
| Enterprise Value | 40.96M SEK |
| Trailing P/E | N/A |
| Forward P/E | -1.6864865 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.8474064 |
| Price/Book (mrq) | 1.5 |
| Enterprise Value/Revenue | 5.233 |
| Enterprise Value/EBITDA | -1.391 |
Trading Information
Cyxone AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.573563 |
| 52-Week Change | 7.50% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.12 SEK |
| 52 Week Low | 0.47 SEK |
| 50-Day Moving Average | 0.69 SEK |
| 200-Day Moving Average | 0.63 SEK |
CYXO.ST Share Statistics
| Avg. Volume (3 month) | 154.37K SEK |
| Avg. Daily Volume (10-Days) | 111.48K SEK |
| Shares Outstanding | 98.44M |
| Float | 80.26M |
| Short Ratio | N/A |
| % Held by Insiders | 24.54% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -401.85% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.76% |
| Return on Equity (ttm) | -55.91% |
Income Statement
| Revenue (ttm) | 7.83M SEK |
| Revenue Per Share (ttm) | 0.08 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 6.4M SEK |
| EBITDA | -29452000 SEK |
| Net Income Avi to Common (ttm) | -31763000 SEK |
| Diluted EPS (ttm) | -0.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 22.39M SEK |
| Total Cash Per Share (mrq) | 0.23 SEK |
| Total Debt (mrq) | 1.34M SEK |
| Total Debt/Equity (mrq) | 3.27 SEK |
| Current Ratio (mrq) | 4.273 |
| Book Value Per Share (mrq) | 0.416 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -36421000 SEK |
| Levered Free Cash Flow (ttm) | -34125124 SEK |
Profile of Cyxone AB (publ)
| Country | Sweden |
| State | N/A |
| City | Malmö |
| Address | Adelgatan 21 |
| ZIP | 221 22 |
| Phone | 46 7 08 88 21 72 |
| Website | https://www.cyxone.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 7 |
Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.
Q&A For Cyxone AB (publ) Stock
What is a current CYXO.ST stock price?
Cyxone AB (publ) CYXO.ST stock price today per share is 0.1 SEK.
How to purchase Cyxone AB (publ) stock?
You can buy CYXO.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cyxone AB (publ)?
The stock symbol or ticker of Cyxone AB (publ) is CYXO.ST.
Which industry does the Cyxone AB (publ) company belong to?
The Cyxone AB (publ) industry is Biotechnology.
How many shares does Cyxone AB (publ) have in circulation?
The max supply of Cyxone AB (publ) shares is 215.93M.
What is Cyxone AB (publ) Price to Earnings Ratio (PE Ratio)?
Cyxone AB (publ) PE Ratio is now.
What was Cyxone AB (publ) earnings per share over the trailing 12 months (TTM)?
Cyxone AB (publ) EPS is -0.18 SEK over the trailing 12 months.
Which sector does the Cyxone AB (publ) company belong to?
The Cyxone AB (publ) sector is Healthcare.
Cyxone AB (publ) CYXO.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Sweden SEK GI FNSESEKGI | 1956.89 SEK 191.02 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1570.14 EUR 1716.38 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care GI FN20GI | 917.04 EUR 1002.44 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 97.9 EUR 107.01 USD |
-0.64
|
— — | — — | — — | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1843.91 SEK 179.99 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1479.5 EUR 1617.29 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care PI FN20PI | 912.9 EUR 997.92 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 123.34 SEK 12.04 USD |
-0.14
|
— — | — — | — — | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 97.96 DKK 14.36 USD |
-0.62
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}